Blog

Cost of NHS prescribing for diabetes rises by more than £500m since 2015/2016

By Katherine Price DR P. MARAZZI/SCIENCE PHOTO LIBRARY The cost of NHS prescribing for diabetes treatment in England has

Asia

The Asia-Pacific Oral Anti-Diabetic Drug Market size is expected to grow from USD 24.61 billion in 2023 to USD 28.67 bil

Risk Adjusted Net Present Value: What is the current valuation of Novo Nordisk's Insulin icodec

Risk Adjusted Net Present Value: What is the current valuation of Novo Nordisk's Insulin icodec

Antidiabetics Market Expected to Reach $143.9 billion by 2032: Players Sanofi

Antidiabetics Market 2023 shows a quantitative fundamental market analysis to provide users with the most recent market

Anti

libre de droit / iStock By subscribing, you agree to our Terms of Use and Policies You may unsubscribe at any time. Ther

Novel Cardioprotective Antidiabetic Medications

Epicardial adipose tissue (EAT) plays an important role in cardiometabolic risk. EAT is a modifiable risk factor and cou

Does Glucerna work for people living with diabetes?

Glucerna is a nutritional supplement meal replacement that may help provide balanced nutrition for people with diabetes.

I definitely would have taken Ozempic to lose weight five years ago—but what else would I have lost?

By Emma Specter Ozempic, the drug traditionally used to treat diabetes, has been steered away from its original purpose,

NNC

NNC-04916075 by Novo Nordisk for Dyslipidemia: Likelihood of Approval

Glenmark Pharmaceuticals gets ANDA approval for its anti

Glenmark Pharmaceuticals gets ANDA approval for its anti-diabetic drug | The Financial Express

First

Bangladesh has launched the first-ever once-weekly oral Anti-diabetic medication as a possible alternative to insulin in

Adherence to antidiabetic drug therapy and reduction of fatal events in elderly frail patients

Cardiovascular Diabetology volume 22, Article number: 53 (2023) Cite this article 1463 Accesses 1 Citations 5 Altmetric